Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Ubiquitin Stories

2014-04-15 12:30:22

Scientist's 'monumental' discoveries underlie one of the largest fields in modern biomedical research, including efforts to treat cancer and neurodegenerative diseases ALBANY, N.Y., April 15, 2014 /PRNewswire-USNewswire/ ----Alexander Varshavsky, Ph.D., whose landmark discoveries transformed the understanding of how cell behavior impacts diseases including cancer, autoimmune disorders and other illnesses, has been selected to receive the prestigious Albany Medical Center Prize in...

2014-03-28 13:39:33

A new chemical messenger that is critical in protecting the brain against Parkinson's disease has been identified by scientists at the Medical Research Council (MRC) Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee. The research team led by Dr Miratul Muqit had previously discovered that mutations in two genes – called PINK1 and Parkin – lead to Parkinson's. Now they have made a completely unexpected discovery about the way the two genes interact, which...

2014-02-03 10:24:50

Disruptive clumps of mutated protein are often blamed for clogging cells and interfering with brain function in patients with the neurodegenerative diseases known as spinocerebellar ataxias. But a new study in fruit flies suggests that for at least one of these diseases, the defective proteins may not need to form clumps to do harm. The study, published February 1, 2014, in the journal Genes and Development, focuses on ataxin-7, the gene that is mutated in patients with spinocerebellar...

2013-11-22 23:20:45

Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery, increased R&D spending in the development of epigenetic tools and assays for Histone Methyltransferases (HMT) research, HMTs use as biomarkers and targets for diagnostics development and the drug discovery sector will drive tremendous growth in this market for the foreseeable future. BCC Research projects the market to grow to $275 million by 2018, and register a five-year compound annual...

2013-10-07 23:20:22

Reportbuyer.com just published a new market research report: Ubiquitin Proteasome: Global Markets for Research Tools, Diagnostics and Drug Discovery. London (PRWEB) October 07, 2013 STUDY GOALS AND OBJECTIVES This BCC Research report, Ubiquitin Proteasome: Global Markets for Research Tools, Diagnostics and Drug Discovery, provides an overview of the current overall state of ubiquitin proteasome market, focusing specifically on research tools, assay development, drug candidates and...

2013-07-23 23:19:33

According to a new technical market research report, the global ubiquitin proteasome research and development market was valued at nearly $2.9 billion in 2013. BCC Research expects the market to reach more than $5.5 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 14.2% for the period 2013 to 2018. Wellesley, MA (PRWEB) July 23, 2013 According to a new technical market research report, Ubiquitin Proteasome: Global Markets for Research Tools, Diagnostics and...

2013-07-23 08:29:36

MINNEAPOLIS, July 23, 2013 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH) (Techne) announced today that J. Fernando Bazan, Ph.D. has been appointed Chief Technology Officer. With global recognition as a scientific leader in fields ranging from structural biology to drug discovery for the treatment of human disorders, Dr. Bazan will be instrumental in directing innovation and influencing future growth in Techne's world-wide market. Dr. Bazan joins Techne with more than twenty years...

2013-05-28 21:38:10

Cells have a sophisticated system to control and dispose of defective, superfluous proteins and thus to prevent damage to the body. Dr. Katrin Bagola and Professor Thomas Sommer of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch as well as Professor Michael Glickman and Professor Aaron Ciechanover of Technion, the Technical University of Israel in Haifa, have now discovered a new function of an enzyme that is involved in this vital process. Using yeast cells as...

2013-04-30 13:46:56

Scientists have devised a method for delivering tumor cell-killing enzymes in a way that protects the enzyme until it can do its work inside the cell. In their study in mBio®, the online open-access journal of the American Society for Microbiology, researchers assembled microscopic protein packages that can deliver an enzyme called PEIII to the insides of cells. By attaching a protein called ubiquitin to the enzyme, they were able to protect it from degradation by the cell, allowing the...

2013-04-09 08:29:31

SAN FRANCISCO, April 9, 2013 /PRNewswire/ -- Cleave Biosciences announced today it has raised $10 million in an extension of its Series A financing from new investor New Enterprise Associates (NEA), bringing its Series A total to $54 million. In the fall of 2011, Cleave raised $44 million from US Venture Partners, 5AM Ventures, Clarus Ventures, OrbiMed Advisors, Astellas Venture Management and Osage University Partners to fund the biopharmaceutical company's cancer drug discovery...